Results of treatment with Telmisartan-Amlodipine in hypertensive patients

Journal of Clinical Hypertension

Volumn 11, Issue 4, 2009, Pages 207-213

  Littlejohn III, Thomas W ^a   Majul, Claudio R ^b   Olvera, Rafael ^c   Seeber, Mary ^d   Kobe, Maureen ^e   Guthrie, Robert ^f   Oigman, Wille ^g   Baglivo, H ^h   Bendersky, M ^h   Kuschnir, E ^h   Rodriguez, P ^h   Villamil, A ^h   Felicio, J ^h   Jardim, P ^h   Kohlman, O ^h   Mion Jr , D ^h   Alpizar, M ^h   Alvarado, R ^h   Illescas, J ^h   Meaney, A ^h   Parra, J ^h   Peralta, R ^h   Rodriguez, I ^h   Sanchez, H ^h   Trevethan, S ^h   Bernhardi, D ^h   Briel, A ^h   Chetty, S ^h   Janari, E ^h   Jurgens, J ^h   Kahanowitz, C ^h   Lakha, D ^h   Makan, H ^h   Mitha, I ^h   Nel, P ^h   Patel, P ^h   Vawda, Z ^h   Wellington, N ^h   Agaiby, J ^h   Anderson, J ^h   Balaji, G ^h   Bays, H ^h   Bertini, N ^h   Bestermann, W ^h   Blaze, K ^h   Borge, A ^h   Boscia III, J ^h   Brobyn, T ^h   Brodnan, J ^h   Brown, V ^h   Cavalieri, T ^h   Chappel, C ^h   Chen, A ^h   Cheung, D ^h   Christensen, S ^h   Chrysant, S ^h   Cooper, C ^h   Copeland, T ^h   De Busk, C ^h   DeSantis, D ^h   Douglas, B ^h   Ervin, J ^h   Fiacco, P ^h   Fiel, T ^h   George, J ^h   Gilderman, L ^h   Gilman, R ^h   Glover, III ^h   Goetsch, A ^h   Graf, R ^h   Graff, A ^h   Graves, M ^h   Gutmann, J ^h   Hall, C ^h   Harper, W ^h   Henry, D ^h   Hidalgo Jr , H ^h   Holland, J ^h   Honeycutt, D ^h   Johnson, C ^h   Khan, A ^h   Khan, B ^h   Klaassen, P ^h   Kozinn, M ^h   Kreis, S ^h   Layne, K ^h   Lee, J ^h   Lewin, A ^h   Liang, C S ^h   Ligon, L ^h   Linder, T ^h   Lipetz, R ^h   Lucas, M ^h   Marple, R ^h   Meli, J ^h   Mello, C ^h   Middleton, R ^h   Mion Bet, S ^h   Mootoo, K ^h   Murray, A ^h   Naidu, J ^h   Narayan, P ^h   Navarro, J ^h   Neutel, J ^h   Niederman, A ^h   Noble, R ^h   Patron, A ^h   Phillips, F ^h   Pleskow, W ^h   Punzi, H ^h   Raad, G ^h   Raoof, T ^h   Raskin, P ^h   Razzetti, A ^h   Reed, L ^h   Resnick, H ^h   Schmidt, J ^h   Schreiman, R ^h   Schumacher, D ^h   Seidner, M ^h   Self, K ^h   Serfer, G ^h   Shapiro, W ^h   Silverfield, J ^h   Slabic, S ^h   Sockolov, R ^h   Sparks, J ^h   Struble, R ^h   Thompson, C ^h   Toth, P ^h   Treimer, T ^h   Vrooman, P ^h   Webster, D ^h   Willis, G ^h   Willsie, S ^h   Wright, D ^h   Yates, S ^h   Shannon, Karen ⁱ   Koval, Steven ⁱ   Singh, Ashish ⁱ   more..

^a Piedmont Medical Research Associates   (United States)

^b Hospital Santojanni Buenos Aires   (Argentina)

^c Clinica de Estudios Medicos SC   (Mexico)

^d Mediclinic Heart Hospital   (South Africa)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h Boehringer Ingelheim ^*

ⁱ BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS TELMISARTAN; PLACEBO; TELMISARTAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FACTORIAL ANALYSIS; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EDEMA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 65449181110     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00098.x     Document Type: Article

References (18)

1. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141-147.
2. Tedesco MA, Natale F, Calabro R. Effects of monotherapy and combination therapy on blood pressure control and target organ damage: A randomized prospective intervention study in a large population of hypertensive patients. J Clin Hypertens. 2006;8:634-641.
3. Weir MR. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade. J Hum Hypertens. 2007;21:770-779.
4. Egan BM. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens. 2007;9:783-789.
5. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 1996;156:1969-1978.
6. Weber MA, Bakris GL, Dahlöf B, et.al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk. Blood Press. 2007;16:13-19.
7. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366:895-906.
8. Kjeldsen SE, Jamerson KA, Bakris GL, et al. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study. Blood Press. 2008;17:7-17.
9. Allemann Y, Fraile B, Lambert M, et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) study. J Clin Hypertens. 2008;10:185-194.
10. Chrysant SG, Melino M, Karki S, et al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther. 2008;30:587-604.
11. Costa FV. Telmisartan standing out in a crowded contest? High Blood Press Cardiovasc Prev. 2006;13:85-94.
12. Fogari R, Derosa G, Zoppi A, et al. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria. Am J Hypertens. 2007;20:417-422.
13. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560-2572.
14. Philipp T, Smith TR, Glazer R, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-580.
15. Jamerson KA, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428.
16. Fogari R, Zoppi A, Derosa G, et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens. 2007.;21:220-224.
17. Schrader J, Salvetti A, Calvo C, et al. The combination of amlodipine/ valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5mg. Int J Clin Pract. 2009;63:217-225.
18. Neldam S, Edwards C, ATHOS Study Group. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study. Am J Geriatr Cardiol. 2006;15:151-160.